Dicot's business concept is to develop the product Libiguin® as a drug for treating sexual dysfunctions. The development takes place on its own up to clinical phases.
Dicots grundare Jarl Wikberg lämnar styrelsen
Press release: Uppsala, November 23, 2020. A summary of the Interim report January - September 2020, for Dicot AB (publ) is now avalible on the company webbsite www.dicot.se .
Press release: Uppsala, November 18, 2020. Dicot has produced its second large-scale batch of the drug substance for Libiguin®. The production has improved significantly, which means that 2.5 times as much drug substance has been produced from the sa...